This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hammond, H. K. Articles by Bloor, C. M. Search for Related Content PubMed PubMed Citation Articles by Hammond, H. K. Articles by Bloor, C. M.

Circulation, Vol 85, 269-280, Copyright © 1992 by American Heart Association

ARTICLES

Myocardial beta-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and circulatory congestion

HK Hammond, DA Roth, PA Insel, CE Ford, FC White, AS Maisel, MG Ziegler and CM Bloor
VAMC San Diego, CA 92161.

BACKGROUND. The volume-overload, high-output state induced by aortocaval fistula is unique because it is not generally associated with marked abnormalities of contractile function. Thus, changes in beta-adrenergic receptor (beta AR) expression should reflect more directly the influence of neurohumoral adrenergic tone, clarifying the manner in which peripheral (neurohumoral) versus primary myocardial factors are operative in decreased beta AR-dependent signal transduction. METHODS AND RESULTS. We examined the beta-adrenergic receptor-responsive adenylyl cyclase pathway in hearts from pigs subjected to volume-overload hypertrophy with circulatory congestion. Nine pigs underwent initial pharmacological and hemodynamic studies, and, 5 weeks after aortocaval fistula placement, when signs of circulatory congestion were evident, these measurements were repeated. Biochemical analyses of plasma and myocardium from these animals and seven normal animals were compared. Experimental animals showed signs of circulatory congestion (tachypnea, weight gain, pulmonary rales) within 3-4 weeks of fistula placement. Necropsy showed ascites and biventricular cardiac hypertrophy, but no fibrosis or inflammation was present on histological inspection. Heart rate responsiveness to beta AR stimulation was blunted, with ED50, for isoproterenol increased 133% (p less than 0.001) after development of circulatory congestion. Biochemical analyses of the beta AR-responsive adenylyl cyclase pathway showed uniform decreases in beta AR number in right atrium, right ventricle, and left ventricle (36-41% decreases, p less than 0.005). Downregulation was selective for beta 1-receptors, and remaining receptors in the right and left ventricles showed low-affinity agonist binding, suggesting an uncoupling from Gs. All measures of adenylyl cyclase activity were diminished significantly in membrane homogenates from the right atrium (mean reduction, 50 +/- 10%) and left ventricle (mean reduction, 44 +/- 8%) after volume overload. Finally, we found that amounts of cardiac Gs, as measured in reconstitution assays, were decreased in both the right atrium (p less than 0.02) and the left ventricle (p less than 0.01) of volume-overloaded animals but that levels of pertussis toxin substrate were unchanged. CONCLUSIONS. Biochemical findings occurred in the absence of myocardial inflammation or fibrosis and without pharmacological interventions, suggesting that circulatory congestion, with attendant elevation in plasma norepinephrine, may be a sufficient stimulus to induce such changes. The data are compatible with a catecholamine-driven beta AR pathway desensitization. Thus, a primary defect in intrinsic contractile function is not a necessary component for abnormalities of the myocardial beta AR-responsive adenylyl cyclase pathway.

This article has been cited by other articles:

				X. Wang, E. Sentex, H. K. Saini, D. Chapman, and N. S. Dhalla Upregulation of {beta}-adrenergic receptors in heart failure due to volume overload Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H151 - H159. [Abstract] [Full Text] [PDF]

				X. Wang, E. Sentex, D. Chapman, and N. S. Dhalla Alterations of adenylyl cyclase and G proteins in aortocaval shunt-induced heart failure Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H118 - H125. [Abstract] [Full Text] [PDF]

				N. Daneshtalab, R. Z. Lewanczuk, A. Russell, and F. Jamali Rheumatoid Arthritis Does Not Reduce the Pharmacodynamic Response to Valsartan J. Clin. Pharmacol., March 1, 2004; 44(3): 245 - 252. [Abstract] [Full Text] [PDF]

				X. Yu, M. Zhang, K. Kyker, E. Patterson, J. L. Benovic, and D. C. Kem Ischemic Inactivation of G Protein-Coupled Receptor Kinase and Altered Desensitization of Canine Cardiac {beta}-Adrenergic Receptors Circulation, November 14, 2000; 102(20): 2535 - 2540. [Abstract] [Full Text] [PDF]

				F. Di Fusco, S. Hashim, and M. B. Anand-Srivastava Volume overload cardiac hypertrophy exhibits decreased expression of Gsalpha and not of Gialpha in heart Am J Physiol Cell Physiol, October 1, 2000; 279(4): C990 - C998. [Abstract] [Full Text] [PDF]

				X. Xu, S. J. Rials, Y. Wu, T. Liu, R. A. Marinchak, and P. R. Kowey Effects of Captopril Treatment of Renovascular Hypertension on beta -Adrenergic Modulation of L-Type Ca2+ Current J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 196 - 200. [Abstract] [Full Text]

				N. Dzimiri Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502. [Abstract] [Full Text] [PDF]

				T. Anzai, N. C. Lai, M. Gao, and H. K. Hammond Dissociation between regional dysfunction and beta -adrenergic receptor signaling in heart failure Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1267 - H1273. [Abstract] [Full Text] [PDF]

				D. A. Roth, C. D. White, D. A. Podolin, and R. S. Mazzeo Alterations in myocardial signal transduction due to aging and chronic dynamic exercise J Appl Physiol, January 1, 1998; 84(1): 177 - 184. [Abstract] [Full Text] [PDF]

				S. Gando, Y. Hattori, Y. Akaishi, J. Nishihira, and M. Kanno Impaired Contractile Response to Beta Adrenoceptor Stimulation in Diabetic Rat Hearts: Alterations in Beta Adrenoceptors-G Protein-Adenylate Cyclase System and Phospholamban Phosphorylation J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 475 - 484. [Abstract] [Full Text]

				J. Zhang, C. Toher, M. Erhard, Y. Zhang, K. Ugurbil, R. J. Bache, T. Lange, and D. C. Homans Relationships Between Myocardial Bioenergetic and Left Ventricular Function in Hearts With Volume-Overload Hypertrophy Circulation, July 1, 1997; 96(1): 334 - 343. [Abstract] [Full Text]

				L. G. Meggs, H.-e. Huang, B. Li, P. Li, J. Coupet, C. V. Hamby, M. Akanuma, Y. Ishikawa, and P. Anversa Coronary artery stenosis in rats affects {beta}-adrenergic receptor signaling in myocytes Cardiovasc Res, January 1, 1997; 33(1): 98 - 109. [Abstract] [Full Text] [PDF]

				N. J. Freedman, S. B. Liggett, D. E. Drachman, G. Pei, M. G. Caron, and R. J. Lefkowitz Phosphorylation and Desensitization of the Human [IMAGE][IMAGE]-Adrenergic Receptor J. Biol. Chem., July 28, 1995; 270(30): 17953 - 17961. [Abstract] [Full Text] [PDF]

				L. Eklund, J. Piuhola, J. Komulainen, R. Sormunen, C. Ongvarrasopone, R. Fassler, A. Muona, M. Ilves, H. Ruskoaho, T. E. S. Takala, et al. Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice PNAS, January 30, 2001; 98(3): 1194 - 1199. [Abstract] [Full Text] [PDF]